USANA Health Sciences (USNA) Tops Q2 EPS by 20c

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.74, $0.20 better than the analyst estimate of $0.54. Revenue for the quarter came in at $236 million versus the consensus estimate of $225.2 million.

GUIDANCE:

USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.61. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $947 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• US Regulators Plan To Speed Authorizations Of New Vapes - WSJ
• Financial Select Sector SPDR ETF (XLF) call put ratio 1 call to 1.6 puts with focus on 8K contracts of January 50 puts
• Beta Technologies launches electric aircraft healthcare flights in North Carolina